Article
The Genetics of Tuberous Sclerosis Complex and Related mTORopathies: Current Understanding and Future Directions.
Genes - 4 Mar 2024
Man Alice, Di Scipio Matteo, Grewal Shan, Suk Yujin, Trinari Elisabetta, Ejaz Resham, Whitney Robyn
Abstract excerpt
The mechanistic target of rapamycin (mTOR) pathway serves as a master regulator of cell growth, proliferation, and survival. Upregulation of the mTOR pathway has been shown to cause malformations of cortical development, medically refractory epilepsies, and neurodevelopmental disorders, collectively described as mTORopathies. Tuberous sclerosis complex (TSC) serves as the prototypical mTORopathy. Characterized by...
Topics
- Humans
- Tuberous Sclerosis
- Tuberous Sclerosis Complex 2 Protein
- Mutation
- Genetic Testing
- TOR Serine-Threonine Kinases
